drugset / Trial / NCT00097435
A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a Phase 2, multi-center, randomized, open-label study to evaluate the safety, tolerability, and efficacy of Albuferon in subjects with hepatitis C (HEP C) who failed to respond to previous interferon alfa therapy.
Timeline
- Start
- 2004-10
- Primary completion
- 2007-08
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Albuferon | Protein / enzyme biologic | — | — |
| Background | Ribavirin | Small molecule | — | — |